VELOXSOL 5 mg Schmelztabletten Germania - germană - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

veloxsol 5 mg schmelztabletten

intas third party sales 2005 s.l. (8184005) - solifenacinsuccinat - schmelztablette - 5 mg - teil 1 - schmelztablette; solifenacinsuccinat (25892) 5 milligramm

VELOXSOL 10 mg Schmelztabletten Germania - germană - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

veloxsol 10 mg schmelztabletten

intas third party sales 2005 s.l. (8184005) - solifenacinsuccinat - schmelztablette - 10 mg - teil 1 - schmelztablette; solifenacinsuccinat (25892) 10 milligramm

Sitagliptin / Metformin hydrochloride Accord Uniunea Europeană - germană - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , dreifach-kombinationstherapie) als ergänzung zu diät und bewegung bei patienten, die unzureichend kontrolliert auf ihren maximalen tolerierten dosis von metformin und sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Sitagliptin-Metformin-Mepha 50/500 mg Filmtabletten Elveția - germană - Swissmedic (Swiss Agency for Therapeutic Products)

sitagliptin-metformin-mepha 50/500 mg filmtabletten

mepha pharma ag - metformini hydrochloridum, sitagliptinum - filmtabletten - metformini hydrochloridum 500 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogola, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 1.025 mg. - diabetes typ 2 - synthetika